Clinical trial
Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal…
NCT00250302 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00250302 |
|---|---|
| Title | Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures |
| Official title | Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | Teva Branded Pharmaceutical Products R&D, Inc. Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Tibial Fracture |
| Intervention type | Procedure |
| Interventions | autologous mesenchymal stem cells implantation |
| Enrollment | 24 |
| Start date | Apr 1, 2009 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Nov 8, 2005 |
| Last update posted | Apr 28, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: